vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
Ponce Financial Group, Inc. is the larger business by last-quarter revenue ($31.4M vs $31.1M, roughly 1.0× LIFECORE BIOMEDICAL, INC. \DE\). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -32.1%, a 68.4% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs -4.5%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $25.0K). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
LFCR vs PDLB — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $31.4M |
| Net Profit | $-10.0M | $10.1M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 43.6% |
| Net Margin | -32.1% | 36.3% |
| Revenue YoY | -4.5% | 37.6% |
| Net Profit YoY | -52.0% | 245.6% |
| EPS (diluted) | $-0.29 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $31.4M | ||
| Q3 25 | $31.1M | $26.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | $35.2M | $24.6M | ||
| Q4 24 | $32.6M | $22.8M | ||
| Q3 24 | $24.7M | $20.2M | ||
| Q2 24 | — | $20.2M | ||
| Q1 24 | $35.7M | $20.5M |
| Q4 25 | — | $10.1M | ||
| Q3 25 | $-10.0M | $6.5M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | $-14.8M | $6.0M | ||
| Q4 24 | $-6.6M | $2.9M | ||
| Q3 24 | $-16.2M | $2.4M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | $15.6M | $2.4M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 43.6% | ||
| Q3 25 | -9.9% | 32.8% | ||
| Q2 25 | — | 30.2% | ||
| Q1 25 | -25.7% | 32.5% | ||
| Q4 24 | -6.0% | 19.6% | ||
| Q3 24 | -46.9% | 15.2% | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | -2.5% | 18.3% |
| Q4 25 | — | 36.3% | ||
| Q3 25 | -32.1% | 24.3% | ||
| Q2 25 | — | 23.0% | ||
| Q1 25 | -42.0% | 24.2% | ||
| Q4 24 | -20.2% | 14.1% | ||
| Q3 24 | -65.7% | 12.1% | ||
| Q2 24 | — | 15.8% | ||
| Q1 24 | 43.8% | 11.8% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | $-0.29 | $0.27 | ||
| Q2 25 | — | $0.25 | ||
| Q1 25 | $-0.47 | $0.25 | ||
| Q4 24 | $-0.25 | $0.11 | ||
| Q3 24 | $-0.53 | $0.10 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | $0.42 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $126.2M |
| Total DebtLower is stronger | $136.0M | $596.1M |
| Stockholders' EquityBook value | $-10.5M | $541.5M |
| Total Assets | $235.2M | $3.2B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $126.2M | ||
| Q3 25 | $18.9M | $146.6M | ||
| Q2 25 | — | $126.6M | ||
| Q1 25 | $5.4M | $129.9M | ||
| Q4 24 | $9.5M | $139.8M | ||
| Q3 24 | — | $155.8M | ||
| Q2 24 | — | $103.2M | ||
| Q1 24 | — | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | $136.0M | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | $124.9M | $521.1M | ||
| Q4 24 | $111.3M | $596.1M | ||
| Q3 24 | $106.3M | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | $97.1M | $680.4M |
| Q4 25 | — | $541.5M | ||
| Q3 25 | $-10.5M | $529.8M | ||
| Q2 25 | — | $521.1M | ||
| Q1 25 | $2.2M | $513.9M | ||
| Q4 24 | $15.4M | $505.5M | ||
| Q3 24 | $-3.9M | $504.6M | ||
| Q2 24 | — | $497.7M | ||
| Q1 24 | $17.7M | $493.7M |
| Q4 25 | — | $3.2B | ||
| Q3 25 | $235.2M | $3.2B | ||
| Q2 25 | — | $3.2B | ||
| Q1 25 | $237.7M | $3.1B | ||
| Q4 24 | $255.4M | $3.0B | ||
| Q3 24 | $246.8M | $3.0B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | $246.2M | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | 56.05× | 1.01× | ||
| Q4 24 | 7.20× | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | 5.49× | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $55.6M |
| Free Cash FlowOCF − Capex | $25.0K | $54.6M |
| FCF MarginFCF / Revenue | 0.1% | 173.9% |
| Capex IntensityCapex / Revenue | 5.6% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $55.6M | ||
| Q3 25 | $1.8M | $1.4M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | $1.2M | $13.1M | ||
| Q4 24 | $-6.1M | $7.2M | ||
| Q3 24 | $-613.0K | $-14.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $-1.4M | $1.5M |
| Q4 25 | — | $54.6M | ||
| Q3 25 | $25.0K | $786.0K | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | $-4.3M | $12.9M | ||
| Q4 24 | $-8.6M | $4.5M | ||
| Q3 24 | $-4.0M | $-15.0M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $-7.8M | $-315.0K |
| Q4 25 | — | 173.9% | ||
| Q3 25 | 0.1% | 2.9% | ||
| Q2 25 | — | 22.4% | ||
| Q1 25 | -12.1% | 52.6% | ||
| Q4 24 | -26.3% | 19.7% | ||
| Q3 24 | -16.3% | -74.1% | ||
| Q2 24 | — | -13.0% | ||
| Q1 24 | -21.8% | -1.5% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | 5.6% | 2.3% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | 15.5% | 0.6% | ||
| Q4 24 | 7.5% | 11.9% | ||
| Q3 24 | 13.9% | 2.0% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | 17.8% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | -0.09× | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
PDLB
Segment breakdown not available.
